Related Experiment Video
Updated: Sep 13, 2025

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
Published on: July 4, 2017
Novel Curcumin Floating Tablets for Spatial Delivery in Peptic Ulcer
Chitra Gupta1, Girdhar Kumar Sahu1, Ashish Kumar Parashar1
1Department of Pharmaceutics, Lloyd Institute of Management and Technology, Greater Noida, 201306, India.
This study developed novel floating tablets to improve curcumin delivery for peptic ulcer treatment. The gastroretentive system enhances curcumin
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Natural Product Therapeutics
Background:
- Peptic ulcers are commonly treated with drugs that have side effects.
- Curcumin shows therapeutic potential but suffers from poor solubility and instability.
- Novel drug delivery systems are needed to enhance curcumin's efficacy for peptic ulcer treatment.
Purpose of the Study:
- To develop an innovative drug delivery system to overcome curcumin's bioavailability limitations.
- To formulate effervescent, gastroretentive tablets for sustained gastric retention and localized curcumin release.
Main Methods:
- Curcumin solubility was enhanced through complexation with methyl-β-cyclodextrin.
- Effervescent, gastroretentive tablets were formulated using hypromellose and gas-generating agents.
- Tablet properties, gastroretention, and in vitro drug release were evaluated.
Main Results:
- Tablets met pharmaceutical standards for hardness, friability, and drug content.
- Tablets achieved rapid flotation (within 20s) and sustained buoyancy for ~16 hours.
- In vitro studies showed sustained drug release (73.92% in 9h) via quasi-Fickian diffusion.
Conclusions:
- A novel floating tablet system effectively enhances curcumin delivery for peptic ulcer management.
- The system utilizes cyclodextrin complexation and gastroretentive properties for improved bioavailability.
- This approach holds promise for addressing unmet needs in peptic ulcer treatment.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

